No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Vivo Surgical’s KLARO™ In vivo Lighting Device Provides Unparalleled Illumination of Surgical Cavities

Editor: What To Know

  • This innovative, cost-effective solution – which is already being used in oncology, gynaecology, head and neck, and general surgery in over 20 countries – is helping to improve patient outcomes and accelerate recovery times by minimizing the size of surgical incisions, as well as relieving eye fatigue and ergonomic issues faced by surgeons.
  • The FDA registered, CE certified device clips easily onto surgical drapes, with a long light strip to allow effective hands-free positioning of the light within the surgical cavity.
  • As a clinician-driven company, Vivo Surgical is always looking to further expand the application of its novel lighting solutions, and is keen to enter into new collaborative ventures and distribution partnerships worldwide.

Vivo Surgical’s KLARO™ in vivo lighting device is designed to revolutionize surgical illumination and provide a clearer view of surgical cavities. Developed in partnership with SingHealth – Singapore’s largest group of healthcare institutions – and Panasonic Lighting (Europe), this innovative LED light solution solves many of the problems associated with traditional operating theatre lighting and personal headlights.

Inadequate surgical lighting has been identified as one of the key challenges in operating theatres, particularly in complex open procedures involving deep or narrow surgical cavities. KLARO is designed specifically to eliminate this issue, giving a better view of the surgical site while eliminating the ergonomic problems associated with headtorches. The flexible LED tip offers four lighting intensities, with a compact, 4.6 mm diameter to make it easy to position during surgery, ensuring wide-angle illumination.

The single-use KLARO has been developed specifically for surgical use, offering up to four hours of consistent in vivo illumination while maintaining a safe operating temperature of below 38 °C/100°F. The FDA registered, CE certified device clips easily onto surgical drapes, with a long light strip to allow effective hands-free positioning of the light within the surgical cavity. It can also be used to transform any existing surgical retractor into a lit one using the supplied silicone retractor loops, offering seamless integration with existing instruments to minimize workflow disruption. This innovative, cost-effective solution – which is already being used in oncology, gynaecology, head and neck, and general surgery in over 20 countries – is helping to improve patient outcomes and accelerate recovery times by minimizing the size of surgical incisions, as well as relieving eye fatigue and ergonomic issues faced by surgeons.

As a clinician-driven company, Vivo Surgical is always looking to further expand the application of its novel lighting solutions, and is keen to enter into new collaborative ventures and distribution partnerships worldwide. In particular, the company is currently seeking partners with expertise in operating room consumables.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy